Skip to main content
Top
Published in: BMC Pediatrics 1/2020

01-12-2020 | Proton Pump Inhibitors | Research article

Natural history of gastroesophageal reflux in infancy: new data from a prospective cohort

Authors: Marlène Curien-Chotard, Prévost Jantchou

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Gastroesophageal reflux (GER) is common in infants. Gastroesophageal reflux disease (GERD) is defined as GER leading to troublesome symptoms that affect daily functioning and/or complications. This study is aimed at determining the prevalence and progression of GER and GERD in a cohort of healthy term infants from birth to 12 months old.

Methods

We conducted a prospective cohort study including all full-term living neonates born at Besançon Teaching Hospital, France. Parents completed a clinical report form and the Infant Gastroesophageal Reflux Questionnaire-Revised (I-GERQ-R) at 1, 3, 6, 10, and 12 months of age. GER was defined as score ≥ 1 to the first question with I-GERQ-R score < 16, and GERD as score ≥ 1 to the first question with I-GERQ-R score ≥ 16. Regurgitation was based on the answer to the first question of the I-GERQ-R as anything coming out of the mouth daily.

Results

157/347 births were included (83 boys). The prevalence of regurgitation at least once a day was 45.7% overall. In total: 72, 69, 56, 18, and 13% of infants regurgitated at least once a day at 1, 3, 6, 10, and 12 months of age, respectively. Physiological GER affected 53, 59, 51, 16, and 12% of infants; GERD, 19, 9, 5, 2, and 2%, respectively. Two risk factors were identified: family history of GER and exposure to passive smoking. Treatment included dietary modification (14%) and pharmacotherapy (5%).

Conclusion

Physiological GER peaked at 3 months, GERD at 1 month. Most cases resolved on their own. GER and GERD are very common in the infant’s population and parents should be reassured/educated regarding symptoms, warning signs, and generally favorable prognosis. I-GERQ-R is useful to the clinical screening and follow up for GER and GERD.
Literature
1.
go back to reference Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the north American Society for Pediatric Gastroenterology, Hepatology, and nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49(4):498–547.CrossRef Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the north American Society for Pediatric Gastroenterology, Hepatology, and nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49(4):498–547.CrossRef
2.
go back to reference Gottrand F. Gastroesophageal reflux in childhood. Arch Pediatr. 2006;13(7):1076–9.CrossRef Gottrand F. Gastroesophageal reflux in childhood. Arch Pediatr. 2006;13(7):1076–9.CrossRef
3.
go back to reference Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. Pediatric Gastroesophageal reflux clinical practice guidelines: joint recommendations of the north American Society for Pediatric Gastroenterology, Hepatology, and nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and nutrition. J Pediatr Gastroenterol Nutr [Internet]. 2018;66(3):516–54.CrossRef Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. Pediatric Gastroesophageal reflux clinical practice guidelines: joint recommendations of the north American Society for Pediatric Gastroenterology, Hepatology, and nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and nutrition. J Pediatr Gastroenterol Nutr [Internet]. 2018;66(3):516–54.CrossRef
4.
go back to reference Martigne L, Seguy D, Pellegrini N, Orlikowski D, Cuisset J-M, Carpentier A, et al. Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr. 2010;29(1):60–4.CrossRef Martigne L, Seguy D, Pellegrini N, Orlikowski D, Cuisset J-M, Carpentier A, et al. Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr. 2010;29(1):60–4.CrossRef
5.
go back to reference Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric practice research group. Arch Pediatr Adolesc Med. 1997;151(6):569–72.CrossRef Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric practice research group. Arch Pediatr Adolesc Med. 1997;151(6):569–72.CrossRef
6.
go back to reference Martin AJ, Pratt N, Kennedy JD, Ryan P, Ruffin RE, Miles H, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics. 2002;109(6):1061–7.CrossRef Martin AJ, Pratt N, Kennedy JD, Ryan P, Ruffin RE, Miles H, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics. 2002;109(6):1061–7.CrossRef
7.
go back to reference Campanozzi A, Boccia G, Pensabene L, Panetta F, Marseglia A, Strisciuglio P, et al. Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey. Pediatrics. 2009;123(3):779–83.CrossRef Campanozzi A, Boccia G, Pensabene L, Panetta F, Marseglia A, Strisciuglio P, et al. Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey. Pediatrics. 2009;123(3):779–83.CrossRef
8.
go back to reference Van Howe RS, Storms MR. Gastroesophageal reflux symptoms in infants in a rural population: longitudinal data over the first six months. BMC Pediatr. 2010;10:7.CrossRef Van Howe RS, Storms MR. Gastroesophageal reflux symptoms in infants in a rural population: longitudinal data over the first six months. BMC Pediatr. 2010;10:7.CrossRef
9.
go back to reference Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45(4):421–7.CrossRef Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45(4):421–7.CrossRef
10.
go back to reference De Bruyne P, Christiaens T, Vander Stichele R, Van Winckel M. Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997-2009]. J Pediatr Gastroenterol Nutr. 2014;58(2):220–5.CrossRef De Bruyne P, Christiaens T, Vander Stichele R, Van Winckel M. Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997-2009]. J Pediatr Gastroenterol Nutr. 2014;58(2):220–5.CrossRef
11.
go back to reference De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child. 2018;103(1):78–82.CrossRef De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child. 2018;103(1):78–82.CrossRef
12.
go back to reference Illueca M, Alemayehu B, Shoetan N, Yang H. Proton pump inhibitor prescribing patterns in newborns and infants. J Pediatr Pharmacol Ther. 2014;19(4):283–7.PubMedPubMedCentral Illueca M, Alemayehu B, Shoetan N, Yang H. Proton pump inhibitor prescribing patterns in newborns and infants. J Pediatr Pharmacol Ther. 2014;19(4):283–7.PubMedPubMedCentral
13.
go back to reference Orenstein SR, Cohn JF, Shalaby TM, Kartan R. Reliability and validity of an infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila). 1993;32(8):472–84.CrossRef Orenstein SR, Cohn JF, Shalaby TM, Kartan R. Reliability and validity of an infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila). 1993;32(8):472–84.CrossRef
14.
go back to reference Orenstein SR, Shalaby TM, Cohn JF. Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila). 1996;35(12):607–14.CrossRef Orenstein SR, Shalaby TM, Cohn JF. Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila). 1996;35(12):607–14.CrossRef
15.
go back to reference Kleinman L, Rothman M, Strauss R, Orenstein SR, Nelson S, Vandenplas Y, et al. The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument. Clin Gastroenterol Hepatol. 2006;4(5):588–96.CrossRef Kleinman L, Rothman M, Strauss R, Orenstein SR, Nelson S, Vandenplas Y, et al. The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument. Clin Gastroenterol Hepatol. 2006;4(5):588–96.CrossRef
16.
go back to reference Iacono G, Merolla R, D’Amico D, Bonci E, Cavataio F, Di Prima L, et al. Gastrointestinal symptoms in infancy: a population-based prospective study. Dig Liver Dis. 2005;37(6):432–8.CrossRef Iacono G, Merolla R, D’Amico D, Bonci E, Cavataio F, Di Prima L, et al. Gastrointestinal symptoms in infancy: a population-based prospective study. Dig Liver Dis. 2005;37(6):432–8.CrossRef
17.
go back to reference Salvatore S, Hauser B, Vandemaele K, Novario R, Vandenplas Y. Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology? J Pediatr Gastroenterol Nutr. 2005;40(2):210–5.CrossRef Salvatore S, Hauser B, Vandemaele K, Novario R, Vandenplas Y. Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology? J Pediatr Gastroenterol Nutr. 2005;40(2):210–5.CrossRef
18.
go back to reference Alaswad B, Toubas PL, Grunow JE. Environmental tobacco smoke exposure and gastroesophageal reflux in infants with apparent life-threatening events. J Okla State Med Assoc. 1996;89(7):233–7.PubMed Alaswad B, Toubas PL, Grunow JE. Environmental tobacco smoke exposure and gastroesophageal reflux in infants with apparent life-threatening events. J Okla State Med Assoc. 1996;89(7):233–7.PubMed
19.
go back to reference Hallit S, Salameh P. Exposure to toxics during pregnancy and childhood and asthma in children: a pilot study. J Epidemiol Glob Health. 2017;7(3):147–54.CrossRef Hallit S, Salameh P. Exposure to toxics during pregnancy and childhood and asthma in children: a pilot study. J Epidemiol Glob Health. 2017;7(3):147–54.CrossRef
20.
go back to reference Zheng ZL, Deng HY, Wu CP, Lam WL, Kuok WS, Liang WJ, et al. Secondhand smoke exposure of children at home and prevalence of parental smoking following implementation of the new tobacco control law in Macao. Public Health mars. 2017;144:57–63.CrossRef Zheng ZL, Deng HY, Wu CP, Lam WL, Kuok WS, Liang WJ, et al. Secondhand smoke exposure of children at home and prevalence of parental smoking following implementation of the new tobacco control law in Macao. Public Health mars. 2017;144:57–63.CrossRef
21.
go back to reference Peeters S, Vandenplas Y. Sex ratio of gastroesophageal reflux in infancy. J Pediatr Gastroenterol Nutr. 1991;13(3):314.CrossRef Peeters S, Vandenplas Y. Sex ratio of gastroesophageal reflux in infancy. J Pediatr Gastroenterol Nutr. 1991;13(3):314.CrossRef
22.
go back to reference El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.CrossRef El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.CrossRef
23.
go back to reference Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106(6):642–9.CrossRef Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106(6):642–9.CrossRef
24.
go back to reference Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut. 2003;52(8):1085–9.CrossRef Mohammed I, Cherkas LF, Riley SA, Spector TD, Trudgill NJ. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut. 2003;52(8):1085–9.CrossRef
25.
go back to reference He J, Ma X, Zhao Y, Wang R, Yan X, Yan H, et al. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the systematic investigation of gastrointestinal diseases in China. BMC Gastroenterol. 2010;10:94.CrossRef He J, Ma X, Zhao Y, Wang R, Yan X, Yan H, et al. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the systematic investigation of gastrointestinal diseases in China. BMC Gastroenterol. 2010;10:94.CrossRef
26.
go back to reference Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology. 2007;132(1):87–95.CrossRef Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology. 2007;132(1):87–95.CrossRef
27.
go back to reference Heacock HJ, Jeffery HE, Baker JL, Page M. Influence of breast versus formula milk on physiological gastroesophageal reflux in healthy, newborn infants. J Pediatr Gastroenterol Nutr. 1992;14(1):41–6.CrossRef Heacock HJ, Jeffery HE, Baker JL, Page M. Influence of breast versus formula milk on physiological gastroesophageal reflux in healthy, newborn infants. J Pediatr Gastroenterol Nutr. 1992;14(1):41–6.CrossRef
28.
go back to reference Hassall E. Over-prescription of acid-suppressing medications in infants: how it came about, why it’s wrong, and what to do about it. J Pediatr. 2012;160(2):193–8.CrossRef Hassall E. Over-prescription of acid-suppressing medications in infants: how it came about, why it’s wrong, and what to do about it. J Pediatr. 2012;160(2):193–8.CrossRef
29.
go back to reference Joret-Descout P, Dauger S, Bellaiche M, Bourdon O, Prot-Labarthe S. Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit. Int J Clin Pharm. 2017;39(1):181–6.CrossRef Joret-Descout P, Dauger S, Bellaiche M, Bourdon O, Prot-Labarthe S. Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit. Int J Clin Pharm. 2017;39(1):181–6.CrossRef
30.
go back to reference Van der Pol RJ, Smits MJ, van Wijk MP, Omari TI, Tabbers MM, Benninga MA. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics. 2011;127(5):925–35.CrossRef Van der Pol RJ, Smits MJ, van Wijk MP, Omari TI, Tabbers MM, Benninga MA. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics. 2011;127(5):925–35.CrossRef
31.
go back to reference Orenstein SR. Symptoms and reflux in infants: infant Gastroesophageal reflux questionnaire revised (I-GERQ-R)--utility for symptom tracking and diagnosis. Curr Gastroenterol Rep. 2010;12(6):431–6.CrossRef Orenstein SR. Symptoms and reflux in infants: infant Gastroesophageal reflux questionnaire revised (I-GERQ-R)--utility for symptom tracking and diagnosis. Curr Gastroenterol Rep. 2010;12(6):431–6.CrossRef
Metadata
Title
Natural history of gastroesophageal reflux in infancy: new data from a prospective cohort
Authors
Marlène Curien-Chotard
Prévost Jantchou
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02047-3

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue